Total Payments
$791.46
2024 Payments
$151.29
Companies
14
Transactions
34
Medicare Patients
2,341
Medicare Billing
$468,930
Payment Breakdown by Category
Food & Beverage$791.46 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $791.46 | 34 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $167.79 | 4 | $0 (2024) |
| Biogen, Inc. | $134.71 | 8 | $0 (2019) |
| Acorda Therapeutics, Inc | $116.70 | 1 | $0 (2019) |
| Genentech USA, Inc. | $114.38 | 4 | $0 (2018) |
| Allergan Inc. | $109.31 | 7 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $30.89 | 2 | $0 (2019) |
| Medtronic USA, Inc. | $19.55 | 1 | $0 (2017) |
| Ipsen Biopharmaceuticals, Inc | $16.85 | 1 | $0 (2017) |
| ACADIA Pharmaceuticals Inc | $14.44 | 1 | $0 (2017) |
| Alexion Pharmaceuticals, Inc. | $14.30 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $151.29 | 3 | ABBVIE INC. ($151.29) |
| 2023 | $16.50 | 1 | AbbVie Inc. ($16.50) |
| 2019 | $184.27 | 5 | Acorda Therapeutics, Inc ($116.70) |
| 2018 | $125.70 | 8 | Biogen, Inc. ($33.99) |
| 2017 | $313.70 | 17 | Genentech USA, Inc. ($95.70) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $67.49 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: NEUROSCIENCE | ||||||
| 01/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $68.50 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2023 | AbbVie Inc. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2019 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Food and Beverage | Cash or cash equivalent | $116.70 | General |
| Category: PARKINSONS DISEASE | ||||||
| 05/20/2019 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2019 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Neurology | ||||||
| 04/25/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: HYPERHYDROSIS | ||||||
| 04/12/2019 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | Cash or cash equivalent | $15.26 | General |
| Category: NEUROLOGY | ||||||
| 10/26/2018 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Central Nervous System | ||||||
| 10/05/2018 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Immunology | ||||||
| 09/11/2018 | Allergan Inc. | BOTOX - SPASTICITY (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: SPASTICITY | ||||||
| 08/28/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/20/2018 | GENZYME CORPORATION | AUBAGIO (Drug), MS DISEASE STATE | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 07/16/2018 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Immunology | ||||||
| 06/19/2018 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA, PLEGRIDY | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: NEUROLOGY | ||||||
| 03/05/2018 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA, ZINBRYTA | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: NEUROLOGY | ||||||
| 11/01/2017 | Genentech USA, Inc. | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: None | ||||||
| 06/28/2017 | Medtronic USA, Inc. | OSTEOCOOL RF ABLATION (Device) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 06/08/2017 | Biogen, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.96 | General |
| 05/17/2017 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2017 | Allergan Inc. | BOTOX CHRONIC MIGRAINE (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: ANTI-MIGRAINE | ||||||
| 05/11/2017 | Genentech USA, Inc. | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $61.96 | General |
| Category: None | ||||||
| 05/08/2017 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Immunology | ||||||
| 04/18/2017 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 625 | 17,211 | $624,778 | $173,581 |
| 2022 | 10 | 705 | 7,391 | $459,843 | $137,346 |
| 2021 | 7 | 576 | 663 | $309,916 | $102,274 |
| 2020 | 7 | 435 | 470 | $193,151 | $55,729 |
Total Patients
2,341
Total Services
25,735
Medicare Billing
$468,930
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 28 | 16,489 | $296,802 | $80,712 | 27.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 229 | 286 | $123,375 | $39,660 | 32.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 146 | 146 | $90,087 | $24,881 | 27.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 28 | 85 | $52,229 | $11,142 | 21.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 61 | 62 | $24,924 | $6,447 | 25.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 40 | $12,961 | $4,029 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $10,945 | $2,383 | 21.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $6,512 | $1,600 | 24.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 22 | $4,620 | $1,460 | 31.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 48 | 48 | $2,323 | $1,267 | 54.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 262 | 347 | $145,273 | $48,848 | 33.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 23 | 6,600 | $118,800 | $32,180 | 27.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 177 | 177 | $105,601 | $29,879 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 86 | $26,944 | $7,515 | 27.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 40 | 41 | $23,950 | $6,806 | 28.4% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 23 | 33 | $14,223 | $4,472 | 31.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $12,991 | $3,364 | 25.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $6,706 | $1,928 | 28.7% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 49 | 51 | $1,947 | $1,422 | 73.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 12 | $3,408 | $931.45 | 27.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 211 | 287 | $117,957 | $44,016 | 37.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 216 | 216 | $126,792 | $39,357 | 31.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 37 | 37 | $21,053 | $6,295 | 29.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 50 | 61 | $18,788 | $5,692 | 30.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 23 | 23 | $10,856 | $2,831 | 26.1% |
About Dr. Samira Dabiri Zanjani, M.D
Dr. Samira Dabiri Zanjani, M.D is a Neurology healthcare provider based in West Chester, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2012. The National Provider Identifier (NPI) number assigned to this provider is 1487911764.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samira Dabiri Zanjani, M.D has received a total of $791.46 in payments from pharmaceutical and medical device companies, with $151.29 received in 2024. These payments were reported across 34 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($791.46).
As a Medicare-enrolled provider, Dabiri Zanjani has provided services to 2,341 Medicare beneficiaries, totaling 25,735 services with total Medicare billing of $468,930. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location West Chester, PA
- Active Since 04/11/2012
- Last Updated 09/11/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1487911764
Products in Payments
- UBRELVY (Drug) $167.79
- INBRIJA (Drug) $116.70
- TYSABRI (Biological) $115.75
- Non-Covered Product (Drug) $76.91
- BOTOX CHRONIC MIGRAINE (Drug) $39.93
- OCREVUS (Biological) $37.47
- BOTOX (Biological) $23.86
- OSTEOCOOL RF ABLATION (Device) $19.55
- Dysport 300 U-1 (Drug) $16.85
- GILENYA (Drug) $16.55
- BOTOX - SPASTICITY (Drug) $16.43
- BOTOX THERAPEUTIC (Biological) $15.93
- NUPLAZID (Drug) $14.44
- MAYZENT (Drug) $14.34
- SOLIRIS (Drug) $14.30
- Epidiolex (Drug) $14.11
- AJOVY (Drug) $14.04
- BOTOX NEURO REHAB (Drug) $13.16
- AUBAGIO (Drug) $12.33
- Reveal LINQ (Device) $12.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in West Chester
Dr. Mark Callow, Md, MD
Neurology — Payments: $62,306
Neurology $62,306
Joyce Liporace, Md, MD
Neurology — Payments: $34,530
Neurology $34,530
Etsegenet Tizazu, Md, MD
Neurology — Payments: $15,354
Neurology $15,354
Dr. Fred Weinblatt, Md, MD
Neurology — Payments: $14,662
Neurology $14,662
Dr. Mark Macnealy, Do, Jd, DO, JD
Neurology — Payments: $7,323
Neurology $7,323
Dr. Mohamad Rahwan, M.d, M.D
Neurology — Payments: $5,191
Neurology $5,191